MedTrace Logo

Kefir, Gut Microbiota, and Athletic Performance in Soccer Players

NCT06753422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-12-31

No results posted yet for this study

Summary

This research work is a clinical trial that will assess the impact of kefir consumption on the gut microbiota profile and athletic performance of female soccer players of age 18-29 years. The participants were divided into two groups namely the kefir intervention group and the control group. The primary end points are the modifications in the alpha diversity of the gut microbiome and the beta diversity of the gut microbiome and also the athletic performance outcomes like VO2 max and finishing speed which will be measured using the 30-15 Intermittent Fitness Test. The other outcomes of the study are the changes in the body composition (measured through BIA and skinfold), the changes in the dietary intake and the variations in certain microbial genera such as Akkermansia muciniphila and Faecalibacterium prausnitzii.

The study will be the first to evaluate whether kefir intake can increase the microbial diversity, increase the VO2max and improve the body composition of professional athletes. The anticipated outcomes of this study are enhanced gut microbial diversity, enhanced VO2max and finishing speed, and positive alteration in the body composition parameters.

Conditions

  • Gut Microbiota Diversity and Composition
  • Athletic Performance
  • Functional Food Intervention (Kefir)
  • Body Composition
  • Dietary Intake Patterns

Interventions

DIETARY_SUPPLEMENT

Kefir

200 ml/day kefir The primary intervention in our study is the daily consumption of kefir (200 ml/day). No additional drug or medical device was used during the intervention or data collection process. The study focused solely on kefir consumption and its effects on athletic performance and gut microbiota.

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Principal Investigators

  • Duygu Sağlam, Associate Professor · Acibadem University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-06-05
Completion
2024-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06753422 on ClinicalTrials.gov